Sinco Pharmaceuticals files directors list with Hong Kong Stock Exchange

• Sinco Pharmaceuticals filed an updated list of directors with Hong Kong Exchange dated April 30, 2026.
• Board lineup shows two executive directors, led by vice chairman Huang Zhijian, with Lei Shifeng also serving as executive director.
• Non-executive representation includes Jing Huan.
• Independent non-executive directors include lead independent director Bai Zhizhong, with Lau Ying Kit, Wang Qing, Liu Wenfang also listed.
• Committee structure assigns Lau Ying Kit as chair of audit committee plus internal control and corporate governance committee, with Wang Qing chairing remuneration committee.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Sinco Pharmaceuticals Holdings Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260430-12140384), on April 30, 2026, and is solely responsible for the information contained therein.